ARCHIVES

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

This article is from The Cancer Letter archive.

Vol. 02 No. 13 | March 26, 1976

Download PDF Visit The Full Archive

Related Articles

Eight Firms Join AACR As Sustaining Members

April 25, 1997

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010

ACS Chief Medical Officer Brawley Urges Audit Of I-ELCAP Lung Screening Data.

September 26, 2008

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

CCI Gets Qualified Approval To Continue

January 18, 1980

Tobacco Control and Prevention Saved 795,000 Lives Between 1975-2000, Study Shows

March 30, 2012